Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myITPteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
October 5
 · 
Be the first to react
A myITPteam Member

@A myITPteam Member That is really good to hear that you are not experiencing bleeding despite such a low count. Hoping Wednesday’s conversation brings some clarity and a clear next step! Keep us posted ☺️

October 8
A myITPteam Member

Clari- TY for touching base. I'm very fortunate that I do not have bleeding or severe bruising even with a 4K plate count. I will have a conversation with the oncologist on Wednesday to schedule a bone marrow biopsy. My hope is to get an idea of the plate size, production, etc.

October 6
A myITPteam Member

@A myITPteam Member That is a really difficult place to be after so many years of Promacta working. When BTK and SYK inhibitors have also failed, it really narrows the path, this sounds like a conversation worth having urgently with your hematologist if you haven’t already. How are you holding up?

October 6
A myITPteam Member

BTK and SYK inhibitors have been tried and failed.

October 5
myITPteam

That's a really tough situation — nearly a decade of Promacta working and then hitting a wall is genuinely exhausting and scary. A platelet count of 5K is seriously low, so it makes sense that both a bone marrow biopsy and splenectomy are on the table right now.

A bone marrow biopsy helps doctors understand what's happening Show Full Answer

That's a really tough situation — nearly a decade of Promacta working and then hitting a wall is genuinely exhausting and scary. A platelet count of 5K is seriously low, so it makes sense that both a bone marrow biopsy and splenectomy are on the table right now.

A bone marrow biopsy helps doctors understand what's happening at the source — it can reveal whether the bone marrow is producing enough platelets or if something else is going on. This information can guide which treatments might actually work for a specific situation. Splenectomy is typically considered when other treatments haven't kept platelet counts at a safe level. Here's what's generally known about it:

- About 60% of people who have a splenectomy don't need medical therapy again after surgery
- However, it carries lifelong risks, including serious infection and blood clots
- Doctors often delay it when possible, but at 5K platelets with nothing working, it may be a more urgent conversation

There are also newer treatment options worth asking about, including:

- BTK inhibitors like rilzabrutinib (Wayrilz), approved for persistent or chronic ITP that hasn't responded to earlier treatments
- SYK inhibitors like fostamatinib (Tavalisse)
- Anti-CD20 therapies like rituximab

Given how complex this situation is, pushing for a referral to a hematologist who specializes in ITP — if not already involved — could open doors to options that a general hematologist might not immediately consider.

October 5

Related Questions

View All
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In